Study of Motilitone to Treat Functional Dyspepsia

Summary

This study is to evaluate efficacy of the investigational drug Motilitone at 90 mg in patients with Functional Dyspepsia as measured by change in maximum tolerated volume and aggregate symptom score on the nutrient drink test.

Timeline

Start

2015-06

Primary completion

2018-02

Completion

2018-02

Drugs

Indications